4D Molecular Therapeutics (NASDAQ:FDMT) Given New $40.00 Price Target at Bank of America
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) had its price target dropped by stock analysts at Bank of America from $42.00 to $40.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. A number of other brokerages also recently commented on FDMT. Leerink Partners decreased […]
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) had its price target dropped by stock analysts at Bank of America from $42.00 to $40.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. A number of other brokerages also recently commented on FDMT. Leerink Partners decreased […]
